Bimeda markets EQUIMAX under license in the United States and Canada from Virbac Corporation, which is the manufacturer of the product. Bimeda is aware of this incident and has been in contact with the veterinarian who treated the horse. Both companies take such matters very seriously.
   There is no medical evidence to support EQUIMAX as the cause of the horse’s illness and subsequent death. Both companies stand behind the safety and efficacy of EQUIMAX when used as directed.
   EQUIMAX was approved by the U.S. FDA in 2003 and by Health Canada in 2007. In accordance with stringent FDA and Health Canada regulations, EQUIMAX underwent extensive testing before its release to ensure that it is safe for all horses, including foals four weeks of age and older, pregnant and lactating mares, and breeding stallions. Since its release, EQUIMAX has been dispensed to millions of horses in the United States and around the world.
   For questions or concerns please call Bimeda 888-524-6332.


Email comments or questions to [email protected]

Write A Comment